NovoCure Limited Earnings

NovoCure Limited’s revenue jumped 7.81% since last year same period to $167.2Mn in the Q3 2025. On a quarterly growth basis, NovoCure Limited has generated 5.29% jump in its revenue since last 3-months.

NovoCure Limited’s net profit fell -21.92% since last year same period to $-37.27Mn in the Q3 2025. On a quarterly growth basis, NovoCure Limited has generated 7.15% jump in its net profits since last 3-months.

NovoCure Limited’s net profit margin fell -13.09% since last year same period to -22.29% in the Q3 2025. On a quarterly growth basis, NovoCure Limited has generated 11.81% jump in its net profit margins since last 3-months.

NovoCure Limited’s earning per share (EPS) estimates for the current quarter stand at -0.39 - a 5.01% jump from last quarter’s estimates.

NovoCure Limited’s earning per share (EPS) estimates for the current year stand at -0.39.

NovoCure Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the NovoCure Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.